SILENCE KELLER: Open Payments
NPI 1922574938 · BRISTOW, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 29 payments from 10 companies in 2025. Trend: 2023 $568 · 2024 $971 · 2025 $505
Food & beverage: $455Long term medical supply or device loan: $50
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $156 |
| Novo Nordisk Inc | 4 | $78 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| Abbott Laboratories | 1 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Exact Sciences Corporation | 1 | $21 |
| Amgen Inc. | 1 | $20 |
| PFIZER INC. | 1 | $16 |
Products named: QULIPTA, TRELEGY ELLIPTA, VRAYLAR, FREESTYLE INSULINX, Wegovy, Kerendia, TRINTELLIX, AIRSUPRA.
Industry payments across IN — which companies pay providers there.
